Lanreotide 120mg/0.5ml solution for injection pre-filled syringes
NHS hospitals in England used £59,034,748 of indicative cost of Lanreotide 120mg/0.5ml solution for injection pre-filled syringes in the 12 months to July 2026, about 0.2% of all hospital medicines spend. That is up 8.1% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Lanreotide 120mg/0.5ml solution for injection pre-filled syringes: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to July 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Lanreotide 120mg/0.5ml solution for injection pre-filled syringes most
By indicative cost over the 12 months to July 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| Royal Free London Nhs Foundation Trust | £5,176,925 |
| The Christie Nhs Foundation Trust | £3,911,975 |
| Aintree University Hospital Nhs Ft | £3,533,427 |
| Oxford University Hospitals Nhs Ft | £3,502,506 |
| The Newcastle Upon Tyne Hpl Nhs Found Tr | £3,392,877 |
| Sheffield Teaching Hospitals Nhs Trust | £2,925,314 |
| University Hpls Coventry & Warwick Trust | £2,706,993 |
| King's College Hpl Nhs Foundation Trust | £1,806,536 |
| Cambridge Univ Hosp Nhs Foundation Trust | £1,607,892 |
| Imperial College Healthcare Nhs Trust | £1,533,869 |
The primary-care picture
Lanreotide is also dispensed in the community. See the national primary-care prescribing volume, cost and trend on the Lanreotide medicine page.